Example: Heart Attack

Search clinical trials for: Dapsone

Total 69 results

NCT02959970

Completed

Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris

Conditions: Acne Vulgaris
NCT02944461

Completed

Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris

Conditions: Acne
NCT01115244

Terminated

Use of Dapsone Gel, 5% for Treating Dermatitis Herpetiformis

Conditions: Dermatitis Herpetiformis
NCT01870050

Unknown status

Dapsone Prurigo Study

Conditions: Lichen Simples Chronicus and Prurigo
NCT02032407

Completed

A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris

Conditions: Acne Vulgaris
NCT01974323

Completed

Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Conditions: Acne Vulgaris
NCT01974141

Completed

A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris

Conditions: Acne Vulgaris
NCT01165840

Completed

Effect of Weight and/or Obesity on Dapsone Drug Concentrations

Conditions: Obesity; Leprosy; Tuberculosis
NCT03681470

Recruiting

Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color

Conditions: Acne Vulgaris
NCT01144650

Unknown status

Dapsone for Acute Ischemia Stroke Study

Conditions: Cerebral Stroke; Cerebrovascular Accident, Acute; Cerebrovascular Stroke; Stroke, Acute; Stroke
NCT02627417

Unknown status

Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia

Conditions: Adult Immune Thrombocytopenia (ITP); Dapsone
NCT02550080

Unknown status

Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity Syndrome

Conditions: Allergic Cutaneous Vasculitis; Urticaria; Psoriasis; Acne; Bullous Skin Diseases; Sterile Pustulosis; Leprosy; Pneumocystis Pneumonia
NCT01885910

Completed

Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel

Conditions: Acne Vulgaris
NCT02865005

Completed

Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris

Conditions: Acne Vulgaris
NCT01773122

Completed

Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris

Conditions: Acne Vulgaris
NCT01785836

Withdrawn

An Extension Study to Assess the Safety, Tolerability, Efficacy, and Treatment Adherence of Dapsone in Acne Vulgaris

Conditions: Acne Vulgaris
NCT00371735

Completed

Chlorproguanil-Dapsone-Artesunate (CDA) Versus Chlorproguanil-Dapsone (LAPDAP) For Uncomplicated Malaria

Conditions: Malaria, Falciparum
NCT01931150

Completed

Study of Prophylactic Topical Dapsone 5% Gel Versus Moisturizer for Cetuximab-induced Papulopustular (Acneiform) Rash in Patients With mCRC or HNSCC Without Previous or Concurrent RT

Conditions: Cetuximab-induced Papulopustular (Acneiform) Rash Who Have; Metastatic Colorectal Cancer or Head and Neck Squamous Cell Carcinoma
NCT02108483

Completed

Phototoxicity Test of Dapsone Gel in Healthy Volunteers

Conditions: Healthy Volunteers
NCT02117739

Completed

Photoallergy Potential of Dapsone Gel in Healthy Volunteers

Conditions: Healthy Volunteers
NCT02493283

Completed

Pharmacokinetics and Distribution of Dapsone in Leucocytes After Single-dose and Multiple-dose Administration

Conditions: Methemoglobinemia; Linear IgA Bullous Dermatosis
NCT01313728

Completed

A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products

Conditions: Acne Vulgaris
NCT00429533

Terminated

Efficacy of Dapsone as a Steroid Sparing Agent in Pemphigus Vulgaris

Conditions: Pemphigus Vulgaris
NCT00964366

Completed

Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications

Conditions: Acne Vulgaris
NCT00002043

Completed

Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)

Conditions: Pneumonia, Pneumocystis Carinii; HIV Infections